Jeevatva

Home | Jeevatva Biosciences

Kanpur, India · Founded 2023 · $1.8M raised

Headquarters
Kanpur
Founded
2023
Business Model
B2B
Total Funding
$1.8M
Last Round
SeedDec 2025
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Jeevatva Biosciences is a stealth-mode microbiome biotech company, incubated at IIT Kanpur, developing novel Live Biotherapeutic Products to restore homeostasis in the human microbiome -- the diverse communities of bacteria, fungi, and viruses that shape metabolic, digestive, immune, and mental health. The company targets dysbiosis caused by diet, lifestyle, and antibiotic use, with work spanning research through drug discovery for conditions including Type 2 diabetes. Jeevatva was founded by Pawan Kumar, PhD (Stanford, IIT Kanpur).

Summary

Jeevatva is a Biotech company based in Kanpur, India, founded in 2023. It has raised $1.8M in total across 2 rounds, most recently a Seed round in Dec 2025. Investors include Leo Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundDec 2025

Sign up to see all 2 events

Funding: Seed. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Jeevatva on Indexed.vc
<a href="https://indexed.vc/companies/jeevatva"><img src="https://indexed.vc/api/badge/company/jeevatva" alt="Jeevatva on Indexed.vc" width="260" height="76" /></a>